Literature DB >> 1100345

Antibacterial drugs today. I.

A P Ball, J A Gray, J M Murdoch.   

Abstract

Since the development of the sulphonamides in the 1930s and the subsequent development of antibiotics from the 1940s onwards, there have now been many drugs developed which are capable of chemotherapeutic activity in a patient infected by a susceptible micro-organism. This review is concerned with precise descriptions of important groups of antimicrobial drugs, with emphasis being placed on the more recently developed drugs. With each group of drugs the pharmacology, major therapeutic indications, dosages and adverse reactions are discussed. Part I of the article discusses the sulphonamides, the natural and semi-synthetic penicillins, cotrimoxazole, chloramphenicol, tetracyclines, the macrolides, lincomycin and clindamycin, fusidic acid, and the urinary antiseptics. The place of each in therapy is defined.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100345     DOI: 10.2165/00003495-197510010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  124 in total

1.  Use of combinations of trimethoprim and sulfamethoxazole in the treatment of chest infections.

Authors:  D T Hughes
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  Prostatitis. Observations on activity of trimethoprim-sulfamethoxazole in the prostate.

Authors:  E M Meares
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

3.  Letter: Penicillin-resistant Neisseria meningitidis.

Authors:  P Contoyiannis; D A Adamopoulos
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

4.  Clindamycin-associated colitis.

Authors:  L E Cohen; C J McNeill; R F Wells
Journal:  JAMA       Date:  1973-03-19       Impact factor: 56.272

Review 5.  Lincomycin.

Authors:  K Kaplan; L Weinstein
Journal:  Pediatr Clin North Am       Date:  1968-02       Impact factor: 3.278

6.  Toxicology of sulphonamide-trimethoprim combinations.

Authors:  V Udall
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

7.  Nephropathy associated with methicillin therapy.

Authors:  G E Brauninger; J S Remington
Journal:  JAMA       Date:  1968-01-08       Impact factor: 56.272

Review 8.  Clinical significance of protein binding of the penicillins.

Authors:  C M Kunin
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

9.  Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.

Authors:  E M Sellers; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1970 Jul-Aug       Impact factor: 6.875

10.  Trimethoprim resistance determined by R factors.

Authors:  M P Fleming; N Datta; R N Grüneberg
Journal:  Br Med J       Date:  1972-03-18
View more
  2 in total

1.  Interactions with the absorption of tetracyclines.

Authors:  P J Neuvonen
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Influence of nutritional status on plasma levels and relative bioavailability of tetracycline.

Authors:  T C Raghuram; K Krishnaswamy
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.